Hercules Capital Inc (HTGC)

NYSE · Financial · Asset Management · USA

Hercules Capital Inc is a mid cap company (market value between $2 billion and $10 billion) in the Asset Management industry.

Hercules Capital is a specialty finance company that provides senior secured loans to venture capital-backed and institutional-backed companies in technology and life sciences industries. The company invests in structured debt and senior secured debt instruments across technology sub-sectors including software, semiconductors, and telecommunications, as well as life sciences companies in medical devices and bio-pharmaceuticals.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Hercules Capital Inc stock.

Our verdict on HTGC

Undervalued: intrinsic value $23.54 per share, market price $15.63, margin of safety 33.6% (as of 2026-11-17).

Book value at 2.06x, the multiple a 15.7% return on equity justifies, blended with earnings, values the shares at $23.54; the price of $15.63 is 34% below that value.

ETFs with the most weight in HTGC

More on HTGC

Browse

Peers in Asset Management

All 137 Asset Management stocks

Cheaper than HTGC in Asset Management

16 more in this industry show a wider margin of safety.

Is HTGC undervalued or overvalued?

HTGC is undervalued (as of the 2026-11-17 close). Book value at 2.06x, the multiple a 15.7% return on equity justifies, blended with earnings, values the shares at $23.54; the price of $15.63 is 34% below that value.

What is the intrinsic value of HTGC?

$23.54 per share (as of the 2026-11-17 close), against a market price of $15.63. That is a margin of safety of 33.6%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.